Skip to main content

Highlights in NTRK: The Year in Review

Please follow the link below to access Highlights in NTRK: The Year in Review on Medscape's website. This program was developed through the collaboration between the United States and Canadian Academy of Pathology (USCAP) and Medscape. 

Authors: Alexander Drilon, MD; George D. Demetri, MD; Jaclyn F. Hechtman, MD

CME / ABIM MOC Released: 2/19/2021
Valid for credit through: 2/19/2022
Target Audience and Goal StatementThis activity is intended for hematologists/oncologists and pathologists. The goal of this activity is to educate pathologists about the clinical significance of NTRK gene fusions, methods for identifying these fusions, and best practices for optimizing the testing process and supporting the oncology care team.

Learning Objective
Upon completion of this activity, participants will:

Have increased knowledge regarding the
  • Characteristics of NTRK fusion-positive tumors:
  • Key clinical trial data on the treatment of NTRK fusion-positive tumors presented throughout the previous year
Demonstrate greater confidence in their ability to:
  • Communicate with other members of the healthcare team regarding molecular testing results and their implications for patient management 

Accreditation StatementsPresented through a collaboration between United States and Canadian Academy of Pathology and Medscape Education.



In support of improving patient care, Medscape LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians
Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.